Effects of change in P^coj on systemic and coronary haemodynamics and on coronary sinus blood-gases have been studied in 10 open-chested dogs in which the lungs were ventilated with 0.8% haJothane in oxygen, before and after administration of oxprenolol 03 mg kg" ' i.v. The hyperdynamic response of the circulation to hypercapnia was only marginally reduced after oxprenolol (cardiac output increased by 10% as opposed to 16% before oxprenolol). Before and after oxprenolol, hypocapnia caused large reductions of coronary blood flow ( -24% and -20% respectively), while hypercapnia caused large increases of coronary blood flow (+ 59% and + 34% respectively). Oxprcnolol does not appear to modify significantly the circulatory response to arterial carbon dioxide tension.
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SUMMARY
Effects of change in P^coj
on systemic and coronary haemodynamics and on coronary sinus blood-gases have been studied in 10 open-chested dogs in which the lungs were ventilated with 0.8% haJothane in oxygen, before and after administration of oxprenolol 03 mg kg" ' i.v. The hyperdynamic response of the circulation to hypercapnia was only marginally reduced after oxprenolol (cardiac output increased by 10% as opposed to 16% before oxprenolol). Before and after oxprenolol, hypocapnia caused large reductions of coronary blood flow ( -24% and -20% respectively) , while hypercapnia caused large increases of coronary blood flow (+ 59% and + 34% respectively). Oxprcnolol does not appear to modify significantly the circulatory response to arterial carbon dioxide tension.
Blockade of the adrenergic beta-receptors modifies responses of the circulation to changes in P&coi (Ledingham et al., 1970; Foex and Prys-Roberts, 1974 ; Van den Bos, Drake and Noble, 1979) . In the case of hypocarbia, the effect of adrenergic betablockade may be minimal. However, in the case of hypercarbia, blockade of the beta-receptors may result in withdrawal of an important inotropic support. The direct negative inotropic effect of carbon dioxide on the myocardium (Jerusalem and Starling, 1910; Pannier and Brutsaert, 1968; Foex and Fordham, 1972 ) is thus unmasked and cardiovascular depression may occur. Intrinsic beta-sympathomimetic activity is a feature of the effect of some adrenergic beta-receptor antagonists. The enhancement of myocardial performance from intrinsic sympathomimetic activity (ISA) has been well documented in the isolated heart (Fitzgerald, Wale and Austin, 1972; Nayler and Chang, 1973) and it has also been observed in anaesthetized animals (Prys-Roberts et al., 1976) . The presence of ISA may minimize the effect of adrenergic beta-receptor blockade in the case of hypercapnia and may prevent cardiovascular depression. To test this hypothesis, the effects of alterations of P&c O2 on the circulation have been studied before and after the administration of the non-selective adrenergic beta-receptor antagonist oxprenolol. systemic and coronary circulations were studied simultaneously, together with coronary sinus blood-gas tensions to gain more insight into the interaction between adrenergic beta-receptor blockade and carbon dioxide under anaesthesia.
METHODS
Ten unpremedicated dogs (mean weight 15.3 kg, SD 0.8) were studied. After induction of anaesthesia with thiopentone, 15 m kg"' i.v. and endotracheal intubation, anaesthesia was maintained with 0.8-1.0% halothane in oxygen using constant volume intermittent positive pressure ventilation (tidal volume 40 ml kg ~', rate 12 b.p.m.). P&co, was maintained at the required value by adding carbon dioxide to the inspired gas mixture and monitoring end-tidal carbon dioxide concentration with an infra-red analyser. The oesophageal temperature was monitored and maintained within the range of 36.5-37.5 °C by undertable heating. The e.c.g. was recorded. An i.v. infusion of fluid 5 ml kg"' h"' was given. The surgical preparation consisted of the insertion of a 20-cm Teflon catheter in the aortic arch via the left carotid artery followed by left lateral thoracotomy. Two electromagnetic flow transducers were implanted, one around the root of the aorta, the other around the left circumflex coronary artery. A miniature pressure transducer was inserted into the cavity of the left ventricle. Umbilical cannulae were inserted to the pulmonary artery, left atrium and coronary sinus. A pneumatic occluder was inserted around the left circumflex coronary artery to allow zero-flow oclusion.
The following variables were recorded: e.c.g., aortic pressure, left ventricular (LV) pressure, left atrial pressure, pulmonary arterial pressure, aortic flow and left circumflex coronary flow. Electronically derived signals included LV dP/dr, aortic blood acceleration and stroke volume. Details of the methods and calibrations have been given elsewhere (Bun and Foex, 1979) .
Arterial, mixed venous and coronary sinus blood samples were analysed at each stage of the experiment. Po 2 , Pco 2 and pH were measured with electrode systems already described (Hahn, 1969 (Hahn, , 1971 . For determinations of Po 2 , two electrodes were used; one for arterial samples was calibrated with room air and 60% oxygen; the other for mixed venous and coronary sinus blood samples was calibrated with pure nitrogen and 10% oxygen. Corrections for temperature difference were applied according to Kelman and Nunn (1966) and a blood-gas difference of 1.04 was applied for Po 2 . Haemoglobin concentrations were determined by spectrophotometry.
Calculation
Systemic vascular resistance, left ventricular external work, peak left ventricular power and the rate-pressure product were computed as described previously (Burt and Foex, 1979) . Oxygen saturation was calculated using the dissociation curve of Rossing and Cain (1966) . In the calculation of oxygen content, an oxygen combining capacity of 1.34 ml oxygen per gram of haemoglobin was used. Whole body oxygen consumption and myocardial oxygen consumption were calculated from the respective flows and arteriovenous oxygen content differences.
The results were analysed for statistical significance using paired Student's t test.
Experimental programme
Following surgical preparation, the animals were allowed to develop a steady cardiovascular state over a period of 1 h at an end-expiratory carbon dioxide concentration of 5.2%. After the steady state had been achieved, a dose-response curve to isoprenaline was constructed with the infusion rate doubled at each stage from an initial rate of 25 ng kg" ' min~ '. Twenty minutes after completion of the dose-response curve all variables had returned to steady state values; the haemodynamic variables were recorded and arterial, mixed venous and coronary sinus blood samples were withdrawn and immediately analysed. Hypocarbia was obtained by removing carbon dioxide from the inspired gas mixture. Recordings of the haemodynamic variables were taken after 20 min hypocarbia; at the same time blood samples were obtained. Carbon dioxide was then reintroduced and its concentration gradually increased over a period of 5 min to achieve an endtidal concentration of about 10%. Recordings and blood samples were obtained after 20 min hypercarbia. A new normocarbic stage was obtained by reducing end-tidal carbon dioxide to 5.2% and values were found to be stable after 20 min. At normocarbia and after the appropriate recordings and blood samples had been taken, oxprenolol 0.3 mg kg~' was injected i.v. and after 20 min, haemodynamic recordings and blood samples were obtained. The hypocarbic, hypercarbic and normocarbic stages were then repeated. A second dose-response curve to isoprenaline was constructed at normocarbia. At each stage, recordings were taken while respiration was halted (airway pressure 0 cm H 2 O, lung volume at functional residual capacity). At the end of each experiment, the coronary artery flow transducer was calibrated by infusing measured volumes of blood into the left circumflex artery. The heart was removed and weighed.
RESULTS
The dose of oxprenolol chosen produced an eightfold shift of the dose-response curve of heart rate to isoprenaline. The effects of alterations of Pzco* on the haemodynamic values before and after adrenergic beta-receptor blockade are given in table I, while their effects on blood-gases are given in table II.
Effects of adrenergic beta-receptor blockade
At normocarbia, the effect of adrenergic betareceptor blockade was a significant reduction of cardiac output by 9% caused by reduction of stroke volume while heart rate remained unchanged. After administration of oxprenolol, systemic vascular resistance (SVR) increased by 12.5%, while mean arterial pressure increased slightly. A significant but small ( + 0.9mmHg) increase of LVEDP was observed. All indices of Heart rate (beat min ') Stroke volume (ml) Cardiac output (ml min" ' kg" ') Mean arterial pressure (mm Hg) Systemic vascular resistance (dyne s cm" 5 ) LVEDP (mm Hg) Peak aortic flow (ml s" ') Aortic blood acceleration (ml s~2) LV dP/dr max (mm Hg s"') (LVdP/dimax)/IP(s" 1 ) Peak LV power (mW) LV stroke work (mj) LV minute work (J) Coronary blood flow (ml min" ') Mean pulm. an. pressure (mm Hg) Pressure-rate product (units x 10~3) Heart rate (beat min" ') Stroke volume (ml) Cardiac output (ml min" ' kg" ') Mean arterial pressure (mm Hg) Systemic vascular resistance (dyne s cm" 5 ) LVEDP (mm Hg) Peak aortic flow (ml s" ') Aortic blood acceleration (ml t'
2 ) LV dP/dt max (mm Hg s" ') (LVdP/dt max)/IP(s"') Peak LV power (mW) LV stroke work (mj) LV minute work (J) Coronary blood flow (ml min" ') Mean pulm. art. pressure (mm Hg) Pretsure-rate product (units x 10" 3 ) myocardial performance were slightly increased after oxprenolol, but the differences ranged between 2% (aortic blood acceleration) and 7% (LV dP/df max/IP) and did not reach statistical significance. Left ventricular peak power remained unchanged. Reductions of stroke work and minute work were similar to those of coronary flow (-5%) and paralleled the decline of myocardial oxygen consumption. With the exception of an 8% increase of the arterial to mixed venous oxygen content difference, blood-gases and oxygen transport appeared unaffected by oxprenolol.
At hypocarbia, adrenergic beta-receptor blockade was responsible for a small (5%) reduction of heart rate while stroke volume remained unchanged; thus cardiac output was slightly reduced. These changes were not significant. Systemic vascular resistance was increased by only 7% and left ventricular end-diastolic pressure by 0.8 mm Hg. All indices of myocardial performance (aortic blood acceleration ( + 7%), LVdP/dr ( + 6.5%), LVdP/drmax/IP (+10%)) were slightly enhanced after oxprenolol. Left ventricular peak power was increased by 9%. Coronary blood flow and myocardial oxygen consumption were unchanged. With the exception of an 8% increase of the arterial to mixed venous oxygen content difference, blood-gases and oxygen transport were unaffected by oxprenolol. At hypercarbia both heart rate and stroke volume were reduced by approximately 7% after adrenergic beta-receptor blockade. Although relatively large, the 13% reduction of cardiac output did not reach statistical significance. Arterial pressure was slightly reduced after oxprenolol ( -9%) while SVR was slightly increased ( + 8%). Left ventricular end-diastolic pressure was increased ( + 0.9mmHg) after adrenergic beta-receptor blockade. Aortic blood acceleration was reduced by 10% and LV dP/dr max by 6%, while LV dP/dr max/IP was unchanged, LV peak power was also reduced by 10%. Significant reductions of stroke work (-12%) and minute work (-18%) were observed, together with reductions of coronary flow ( -20%). Myocardial oxygen consumption (Km O; ) was reduced by 14%. Since whole body oxygen consumption was reduced after oxprenolol, the arterial to mixed venous oxygen content difference remained unchanged, as did all blood-gas values.
Effect of carbon dioxide on coronary flow and on coronary sinus oxygen tension
Tables I and II describe the effect of carbon dioxide on systemic and coronary haemodynamics. While alterations in the systemic circulation caused by carbon dioxide were of relatively small magnitude both before and after administration of oxprenolol, large differences of coronary blood flow were observed ( fig. 1 ). Before adrenergic beta-receptor blockade, hypocarbia caused a 24% reduction of coronary blood flow (P< 0.005) while hypercarbia caused a 59% increase of coronary blood flow (P < 0.005). These changes of coronary flow were accompanied by large and significant alterations of coronary sinus Po 2 (reduction by 1.4 kPa in response to hypercarbia, increase by 2.1 kPa in response to hypercarbia). The hypodynamic response of the circulation to hypocarbia is demonstrated by the reduction of P^m o , while the hyperdynamic response of the circulation to hypercarbia is shown by the increase of Fm o ,. However, the magnitude of the changes of l^m o , (-11% and +16% respectively) was considerably smaller than that of the alterations of coronary blood flow. After adrenergic betareceptor blockade, hypocarbia caused a 20% reduction of coronary blood flow (P < 0.005) while hypercarbia caused a 34% increase of coronary blood flow (P<0.005). These changes were accompanied by a reduction in coronary sinus Po 2 (Pcs O2 ) of -1.2 kPa with hypocarbia, and an increase in Pcs O2 of 2.1 kPa with hypercarbia. These changes were highly significant. The hypodynamic response to hypocarbia was accompanied by a 6% reduction of ^m Oj and the modest hyperdynamic response to hypercarbia was accompanied by a 6% increase of Fm o ,. Again, the alterations of Pm O: were of small magnitude by comparison with the substantial alterations in coronary blood flow.
DISCUSSION
The effects of adrenergic beta-receptor antagonists on the circulation depend on the properties and dose of the drug and also on the preexisting level of sympathetic activity. The latter may be different in different experimental models, so that comparisons could be difficult.
Comparisons are easier if the same experimental model, the same anaesthetic agent and equipotent doses of two or more beta-receptor antagonists are used. Halothane in oxygen was used to make such comparisons possible. Our own study of the effect of metoprolol (Burt and Foex, 1979 ) fulfills these requirements and may be used for comparison, since both metoprolol 1 mgkg" 1 and oxprenolol 0.3mgkg~' were used in doses producing an eight-fold shift to the right of the dose-response curve of heart rate to isoprenaline, 90 min after injection of the beta-blockers. At normocarbia, the effects of the cardioselective antagonist metoprolol were significant reductions of heart rate (-20%), arterial pressure (-10%), cardiac output (-21 %) and all indices of myocardial performance (-32% for aortic blood acceleration, -31 % for LV dPjdt max, -14% for LV dP/dr max/IP and -27% for LV peak power). Coronary blood flow was reduced by 25% and ^m O: by 27%. All these changes were significant (P< 0.005 except for heart rate for which P was <0.01). This significant reduction of myocardial performance accompanied by a substantial reduction of cardiac output, observed after metoprolol, is in contrast with the maintenance of cardiac performance after equipotent doses of oxprenolol. The only differences attaining statistical significance with oxprenolol were the reductions of cardiac output, and then by only 9% compared with 21% after metoprolol, and the modest increase in LVEDP, by 0.9 mm Hg, while the increase caused by metroprolol was by 1.5 mm Hg. All indices of performance significantly and substantially reduced by metoprolol were unchanged or enhanced after oxprenolol. Although performance was maintained or even enhanced, the small increase of SVR observed after oxprenolol caused a reduction of stroke volume. The differences between the responses to metoprolol and to oxprenolol tested under almost identical conditions and used in equipotent doses could be explained by two factors: cardioselectivity and presence of I SA. If cardioselectivity was the major factor, SVR would be expected to be increased more substantially after administration of the nonselective antagonist oxprenolol. This is not borne out by the experimental results: SVR increased by 13% after oxprenolol and by 15% after metoprolol. Thus the two agents had similar effects on vascular resistance. The differences between effects of equipotent doses of oxprenolol and metoprolol may be explained by intrinsic betasympathomimetic activity, a feature of the effect of oxprenolol. Nayler and Chang (1973) have shown that oxprenolol increases the tension developed by trabecular muscles isolated from the heart of control and of catecholamine-depleted dogs. Increases of contractile force and heart rate have also been observed in reserpinized dogs (Meier, 1970) . In this study, administration of oxprenolol caused no change of heart rate and increased most indices of cardiac performance. This is not the usual pattern of response to adrenergic betareceptor blockade unless the agent exhibits partial agonist activity. Under anaesthesia, removal by oxprenolol of the small effect of adrenergic betareceptor activity on the cardiovascular system was accompanied by some stimulation of the betaadrenoceptors because of the intrinsic betasympathomimetic activity. The two effects cancelled out and oxprenolol appeared to have had little effect on the circulation at normocarbia.
At hypocarbia, the values for all indices of myocardial performance were also slightly increased after oxprenolol, but none of the haemodynamic values was significantly modified. This contrasts with observations made after administration of propanolol: using a dose that caused an eight-fold shift of the dose-response curve of heart rate to isoprenaline (Prys-Roberts et al., 1976) all indices of myocardial performance were decreased and heart rate significantly reduced (Foex and Prys-Roberts, 1974) . This would also indicate that the presence of intrinsic beta-mimetic activity may be advantageous. Because of the increased sympathetic activity of hypercarbia, the administration of betaadrenergic antagonists is likely to have a greater effect on the circulation at hypercarbia than at hypocarbia or at normocarbia. This was described with propranolol: cardiac output was substantially reduced (-34%), while heart rate was reduced by 14% and indices of left ventricular performance decreased by up to 40% (Foex and Prys-Roberts, 1974) . After oxprenolol, the only significant differences were 9% reduction of heart rate and reduction of left ventricular work (-12% for stroke work and -18% for minute work). Of the indices of cardiac performance, LV dP dr max/IP was unaffected, while the other indices were reduced by up to 10%. Such changes were trivial by comparison with those caused by propranolol.
The hyperdynamic response to hypercapnia was decreased by oxprenolol (cardiac output increased only by 10% in response to hypercarbia instead of 16% before beta-adrenergic blockade), while it was inverted by propranolol (cardiac output decreased by 16% in response to hypercarbia instead of increasing by 24% before adrenergic beta-receptor blockade). The inversion of the response to hypercarbia after propranolol is a potential clinical hazard. Although normocarbia may easily be maintained during operation, this may not necessarily be so during the recovery period. Moreover, propranolol may in itself facilitate the development of hypercarbia by decreasing the sensitivity of the chemoreceptors to carbon dioxide (Mutschin et al., 1976) . Oxprenolol does not cause inversion of the response of the circulation to hypercapnia. This difference between the effects of propranolol and those of oxprenolol, two non-selective betareceptor antagonists, can only be attributed to the partial agonist characteristics of oxprenolol. This would reinforce the view that partial agonists may offer some advantages.
In this study, data concerning the effect of carbon dioxide on coronary blood flow are available. Consistent with observations made by other groups (Vance, Brown and Smith, 1973; Case, Greenberg and Moskowitz, 1975; Vance et al., 1979; Van den Bos, Drake and Noble, 1979) , we have observed that hypocarbia caused significant reductions of coronary blood flow and of Pcs Ol while the arterial to coronary sinus oxygen content differences increased. In response to hypercarbia, large increases of coronary blood flow and of coronary sinus oxygen tension were observed while the arterial to coronary sinus oxygen content difference decreased. After adrenergic beta-receptor blockade with oxprenolol, the effects of hypocarbia on coronary blood flow, arterial to coronary sinus oxygen content difference, Pcs o , and Km o , were essentially the same as before blockade. The effect of hypercarbia on coronary blood flow was minimized by adrenergic beta-receptor blockade. However, an increase of coronary blood flow by 34% accompanied by an increase in ^m 0 , of only 5% indicates that carbon dioxide caused coronary vasodilatation even though the adrenergic betareceptors were blocked. Case and his colleagues (1978) have used propranolol in a few of their experiments and observed that hypercarbia caused coronary vasodilatation even in the presence of beta-adrenergic receptor blockade. Van den Bos, Drake and Noble (1979) found no increase of coronary blood flow in response to hypercapnia after administration of sotalol. However, in their study there was, surprisingly, no increase of coronary blood flow, even in the absence of betaadrenergic receptor blockade in the range of Pco 2 3-11 kPa. Our data suggest that, within this range, carbon dioxide causes coronary vasodilatation irrespective of the integrity of beta-adrenergic mechanisms.
The possible clinical implications of this study are three-fold. First, the effect of oxprenolol on the circulation appears to be of small magnitude and the response to hypercarbia is not inverted; such findings suggest that intrinsic sympathomimetic activity could be of clinical significance. Second, the carbon dioxide-induced alterations of coronary blood flow do not appear to be mediated by beta-adrenergic mechanisms; third, hypocarbia with or without adrenergic beta-receptor blockade is capable of severely reducing coronary blood flow and Pcs O] , indicating reduced myocardial oxygen availability.
